Torrent Pharmaceuticals will acquire Unichem Laboratories' branded formulation business in India and Nepal for Rs 3,600 crore.
In an interview to CNBC-TV18, Surajit Pal of Prabhudas Lilladher shared his views and readings of the same.
This deal is good for both the companies, he said.
Expect a lot of consolidation to happen in Torrent Pharma going forward, he added.
For full interview, watch accompanying video...
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
